Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction.

Loi H, Boal F, Tronchere H, Cinato M, Kramar S, Oleshchuk O, Korda M, Kunduzova O.

Front Pharmacol. 2019 Feb 27;10:154. doi: 10.3389/fphar.2019.00154. eCollection 2019.

2.

Differential protein profiling as a potential multi-marker approach for obese patients with heart failure: A retrospective study.

Timotin A, Cinato M, Boal F, Dejean S, Anesia R, Arnaut O, Lagente C, Roncalli J, Desmoulin F, Tronchere H, Kunduzova O.

Sci Rep. 2018 May 21;8(1):7894. doi: 10.1038/s41598-018-26118-9.

3.

Cardioprotective properties of N-terminal galanin fragment (2-15) in experimental ischemia/reperfusion injury.

Pisarenko O, Timotin A, Sidorova M, Studneva I, Shulzhenko V, Palkeeva M, Serebryakova L, Molokoedov A, Veselova O, Cinato M, Boal F, Tronchere H, Kunduzova O.

Oncotarget. 2017 Oct 5;8(60):101659-101671. doi: 10.18632/oncotarget.21503. eCollection 2017 Nov 24.

4.

Inhibition of PIKfyve prevents myocardial apoptosis and hypertrophy through activation of SIRT3 in obese mice.

Tronchere H, Cinato M, Timotin A, Guitou L, Villedieu C, Thibault H, Baetz D, Payrastre B, Valet P, Parini A, Kunduzova O, Boal F.

EMBO Mol Med. 2017 Jun;9(6):770-785. doi: 10.15252/emmm.201607096.

5.

Myocardial protection from ischemia/reperfusion injury by exogenous galanin fragment.

Timotin A, Pisarenko O, Sidorova M, Studneva I, Shulzhenko V, Palkeeva M, Serebryakova L, Molokoedov A, Veselova O, Cinato M, Tronchere H, Boal F, Kunduzova O.

Oncotarget. 2017 Mar 28;8(13):21241-21252. doi: 10.18632/oncotarget.15071.

6.

Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity.

Boal F, Timotin A, Roumegoux J, Alfarano C, Calise D, Anesia R, Parini A, Valet P, Tronchere H, Kunduzova O.

Br J Pharmacol. 2016 Jun;173(11):1850-63. doi: 10.1111/bph.13485. Epub 2016 Apr 20.

7.

PI5P Triggers ICAM-1 Degradation in Shigella Infected Cells, Thus Dampening Immune Cell Recruitment.

Boal F, Puhar A, Xuereb JM, Kunduzova O, Sansonetti PJ, Payrastre B, Tronchère H.

Cell Rep. 2016 Feb 2;14(4):750-759. doi: 10.1016/j.celrep.2015.12.079. Epub 2016 Jan 14.

8.

Apelin regulates FoxO3 translocation to mediate cardioprotective responses to myocardial injury and obesity.

Boal F, Roumegoux J, Alfarano C, Timotin A, Calise D, Anesia R, Drougard A, Knauf C, Lagente C, Roncalli J, Desmoulin F, Tronchere H, Valet P, Parini A, Kunduzova O.

Sci Rep. 2015 Nov 6;5:16104. doi: 10.1038/srep16104.

9.

Insulin promotes Rip11 accumulation at the plasma membrane by inhibiting a dynamin- and PI3-kinase-dependent, but Akt-independent, internalisation event.

Boal F, Hodgson LR, Reed SE, Yarwood SE, Just VJ, Stephens DJ, McCaffrey MW, Tavaré JM.

Cell Signal. 2016 Jan;28(1):74-82. doi: 10.1016/j.cellsig.2015.10.014. Epub 2015 Oct 26.

10.

TOM1 is a PI5P effector involved in the regulation of endosomal maturation.

Boal F, Mansour R, Gayral M, Saland E, Chicanne G, Xuereb JM, Marcellin M, Burlet-Schiltz O, Sansonetti PJ, Payrastre B, Tronchère H.

J Cell Sci. 2015 Feb 15;128(4):815-27. doi: 10.1242/jcs.166314. Epub 2015 Jan 14.

11.

Phosphatidylinositol 5-phosphate: a nuclear stress lipid and a tuner of membranes and cytoskeleton dynamics.

Viaud J, Boal F, Tronchère H, Gaits-Iacovoni F, Payrastre B.

Bioessays. 2014 Mar;36(3):260-72. doi: 10.1002/bies.201300132. Epub 2013 Dec 21. Review.

PMID:
24375703
12.

LG186: An inhibitor of GBF1 function that causes Golgi disassembly in human and canine cells.

Boal F, Guetzoyan L, Sessions RB, Zeghouf M, Spooner RA, Lord JM, Cherfils J, Clarkson GJ, Roberts LM, Stephens DJ.

Traffic. 2010 Dec;11(12):1537-51. doi: 10.1111/j.1600-0854.2010.01122.x. Epub 2010 Oct 15.

13.

A charged prominence in the linker domain of the cysteine-string protein Cspα mediates its regulated interaction with the calcium sensor synaptotagmin 9 during exocytosis.

Boal F, Laguerre M, Milochau A, Lang J, Scotti PA.

FASEB J. 2011 Jan;25(1):132-43. doi: 10.1096/fj.09-152033. Epub 2010 Sep 16.

PMID:
20847230
14.

Fine tuning Exo2, a small molecule inhibitor of secretion and retrograde trafficking pathways in mammalian cells.

Guetzoyan LJ, Spooner RA, Boal F, Stephens DJ, Lord JM, Roberts LM, Clarkson GJ.

Mol Biosyst. 2010 Oct;6(10):2030-8. doi: 10.1039/c0mb00035c. Epub 2010 Aug 9.

PMID:
20697620
15.

Specific functions of BIG1 and BIG2 in endomembrane organization.

Boal F, Stephens DJ.

PLoS One. 2010 Mar 25;5(3):e9898. doi: 10.1371/journal.pone.0009898.

16.

The secretion inhibitor Exo2 perturbs trafficking of Shiga toxin between endosomes and the trans-Golgi network.

Spooner RA, Watson P, Smith DC, Boal F, Amessou M, Johannes L, Clarkson GJ, Lord JM, Stephens DJ, Roberts LM.

Biochem J. 2008 Sep 15;414(3):471-84. doi: 10.1042/BJ20080149.

17.

Cysteine-string protein isoform beta (Cspbeta) is targeted to the trans-Golgi network as a non-palmitoylated CSP in clonal beta-cells.

Boal F, Le Pevelen S, Cziepluch C, Scotti P, Lang J.

Biochim Biophys Acta. 2007 Feb;1773(2):109-19. Epub 2006 Sep 14.

18.

Synaptotagmin 8 is expressed both as a calcium-insensitive soluble and membrane protein in neurons, neuroendocrine and endocrine cells.

Monterrat C, Boal F, Grise F, Hémar A, Lang J.

Biochim Biophys Acta. 2006 Jan;1763(1):73-81. Epub 2005 Dec 13.

19.

The variable C-terminus of cysteine string proteins modulates exocytosis and protein-protein interactions.

Boal F, Zhang H, Tessier C, Scotti P, Lang J.

Biochemistry. 2004 Dec 28;43(51):16212-23.

PMID:
15610015

Supplemental Content

Support Center